Joint in Medical Technology

Shoulder Surgery Doesn't Prevent Return to Sports

... July 10 /PRNewswire-USNewswire/ -- Replacing a joint in any part of the body often leads to a long ... an older individual who receives a total shoulder joint replacement can return to full participation ... who have a total shoulder arthroplasty or joint replacement, were able to return to sports and 85 ...

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

... model for RA, an exceptional restoration of joint structure was observed in the studies, which were ... treatment, thiarabine blocked the development of joint disease at the 60 mg/kg/day dose level and ... used along with histological scoring to evaluate joint and bone destruction. Thiarabine demonstrated ...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... disease, over time it can cause permanent joint deformity and severe disability. RA can occur at ... chronic inflammatory arthropathy manifesting with joint pain and swelling that can lead to joint destruction and debilitation over time. The ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... and utility of golimumab in treating both the joint and skin manifestations of this disease." In ... chronic inflammatory arthropathy manifesting with joint pain and swelling that can lead to joint destruction and debilitation. It is frequently ...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients

... zumab Safety and THE Prevention of Structural joint Damage) study demonstrated that a greater ... inhibition in the progression of structural joint damage compared with patients treated with ... inhibition in the progression of structural joint damage, as measured by the change in the mean ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... effects seen with Femara include hot flashes, joint pain, night sweats, weight gain, nausea, ... effects for Femara include hot flashes, fatigue, joint pain, headache, increase in sweating, swelling ... bone pain, hot flashes, back pain, nausea, joint pain, shortness of breath, tiredness, coughing, ...

Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients

... zumab Safety and THE Prevention of Structural joint Damage) study demonstrated that ACTEMRA(R) ... inhibited the progression of structural joint damage, which is a major cause of disability and ... reduction in the progression of structural joint damage during 24 months of treatment compared ...

ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatient Services

... company, announces its support for the use of The joint Commission's Hospital-Based Inpatient Psychiatric ... and for services upon discharge. Following The joint Commission's successful pilot testing, these ... place for hospitals which are accredited by The joint Commission: Admission ...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

... with hypertension.(2) According to the Seventh joint National Committee on Prevention, Detection, ... Program, JNC 7: The Seventh Report of the joint National Committee on Prevention, Detection, ... Program, JNC 7: The Seventh Report of the joint National Committee on Prevention, Detection, ...

Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain

... pains that come with arthritis and other chronic joint problems(1). One of the most effective ways to ... subjects applied Arthri-Zen Relief Cream(R) to joint "hot spots" three times a day. They were ... such as arthritis, inflammation, swelling, joint stiffness, muscle pain and range of motion. ...

When to Have That Joint Replacement?

... and African-American patients tend to have poorer joint function before undergoing hip or knee ... addition, female patients have less preoperative joint function than male patients across ethnic groups. "Studies have shown that the timing of joint replacement surgery ( ...

Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures

... may not be enough orthopaedic surgeons to provide joint replacements to all who need them. According to ... of orthopaedic surgeons able to perform total joint replacements continues at its current rate: ... of patients may not be able to receive it." joint replacement ( ...

Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery

... effects seen with Femara include hot flashes, joint pain, night sweats, weight gain, nausea, ... effects for Femara include hot flashes, fatigue, joint pain, headache, increase in sweating, swelling ... bone pain, hot flashes, back pain, nausea, joint pain, shortness of breath, tiredness, coughing, ...

Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa

... http://www.kemri-wellcome.org . About the joint Malaria Programme, Tanzania The joint Malaria Programme (JMP) is a joint collaborative link between the National Institute ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... effects seen with Femara include hot flashes, joint pain, night sweats, weight gain, nausea, ... effects for Femara include hot flashes, fatigue, joint pain, headache, increase in sweating, swelling ... bone pain, hot flashes, back pain, nausea, joint pain, shortness of breath, tiredness, coughing, ...

Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)

... of ACTEMRA on the inhibition of structural joint damage in 2009. ACTEMRA is currently under ... the joints. This inflammation causes a loss of joint shape and function, resulting in pain, stiffness and swelling, ultimately leading to irreversible joint destruction and disability. Characteristics of ...

Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study

... to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development ... to Isis Pharmaceuticals and its subsidiaries and joint venture. Isis Pharmaceuticals is a ...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

... measure improvement in the tender and swollen joint count and also include assessment of the ... 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least ... change in mTSS reflects less progression of joint damage. (2) Open-Label Study to RAPID 1 (028) ...

New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients

... the progression of structural joint damage in patients with rheumatoid arthritis ... that treatment with ACTEMRA inhibited structural joint damage, which is a major cause of disability and ... in Albany, New York. "It is critical to stop joint damage as quickly as possible to ...

ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments

... with RA continue to experience symptoms of joint pain and stiffness," said Mark Genovese, M.D., ... of ACTEMRA on the inhibition of structural joint damage in 2009. ACTEMRA is currently under review ... in the joints. This inflammation causes a loss of joint shape and function, resulting in pain, stiffness ...

FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A

... Treatment with Kogenate FS Reduces the Risk of joint Damage and Frequent Bleeds in Children with No ... with severe hemophilia A with no pre-existing joint damage. This important approval provides these ... bleeding into the joints was more beneficial to joint health and function than 'on-demand' treatment of ...

Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period

... to hyaluronate preparations or who have knee joint infections or skin diseases in the area of the ... aseptic technique must be followed to avoid joint infection. It is recommended to avoid strenuous ... more than one course of treatment. J Bone joint Surg Am 84-A, 1619-1623. (5) Puttick MP, Wade ...

Joint Commission Urges Patients to 'Speak Up' About Pain

... of life and higher health care costs. The joint Commission is launching a national campaign to ... pain. The new education campaign is part of The joint Commission's award-winning Speak Up(TM) program ... R. Chassin, M.D., M.P.P., M.P.H., president, The joint Commission. "The Joint Commission encourages ...

Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis

... OA patients who are likely to develop more severe joint destruction as they age. This information should ... Attur of the New York University Hospital for joint Diseases and Dr. Virginia Byers Kraus of the ... Osteoarthritis is a debilitating, degenerative joint disease and the leading cause of physical ...

New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis

... to stop, or at least slow the progression of joint damage. Additionally, new therapies that target ... allows the spinal cord and brain to decrease joint inflammation and joint destruction. Now that this pathway is ...

Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis

... This study investigated what happens to joint symptoms after treatment with Pycnogenol is ... analgesics can help reduce pain and also maintain joint movement, to help the quality of life for people ... Western Ontario McMaster questionnaire for joint function was employed to rate the pain level, and ...

Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections

... Group; chief patient safety officer of the joint Commission and director of the Agency of ... and chief patient safety officer of the joint Commission -- Donald M. Berwick, M.D., MPP, ... Mark R. Chassin, M.D., MPP, MPH, president of the joint Commission -- Carolyn Clancy, M.D., director of ...

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture

... endpoint, a reduction in the angle of a patient's joint contracture to joint contracture from baseline was 13.6% (50 degrees ... (3/21) Note: All data applies to primary joint 30 days after last injection "As described in ...

Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments

... effects seen with Femara include hot flashes, joint pain, night sweats, weight gain, nausea, ... effects for Femara include hot flashes, fatigue, joint pain, headache, increase in sweating, swelling ... bone pain, hot flashes, back pain, nausea, joint pain, shortness of breath, tiredness, ...

BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials

... Durban, Pretoria and Cape Town. BARC S.A. is a joint venture between BARC and LANCET LABORATORIES the ... brings a wealth of local knowledge to the joint venture, having provided a pathology service to the medical community since 1952. The joint venture allows for provision of LANCET ...

Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations

... Chobanian, A.V., et al. Seventh report of the joint National Committee on Prevention, ... Chobanian, A.V., et al. Seventh report of the joint National Committee on Prevention, ... Chobanian AV, et al. The Seventh Report of the joint National Committee on Prevention, ...

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

... pressure, < 120/80 mm Hg (placebo: 1.4%). The joint National Committee on Prevention, ... disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders. For more ... 1. JNC 7 = The Seventh Report of the joint National Committee on Prevention, Detection, ...

Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile

... experienced significant relief in end-stage joint disease pain compared to placebo (P<0.001) when ... trial 659 candidates for primary joint replacement surgery for end-stage joint disease were randomly assigned to receive an oral ...

New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients

... Safety and THE Prevention of Structural joint Damage) trial showed that a greater proportion of ... reduction in the progression of structural joint damage, which is critical to RA patients because joint damage leads to disability. The study analysis ...

VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy

... effects seen with Femara include hot flashes, joint pain, night sweats, weight gain, nausea, ... effects for Femara include hot flashes, fatigue, joint pain, headache, increase in sweating, swelling ... bone pain, hot flashes, back pain, nausea, joint pain, shortness of breath, tiredness, ...

Osteoarthritis: Which Treatments Work and Which Don't?

... -- These five recommendations include total joint replacement (96%); unicompartmental knee replacement (76%); osteotomy and joint preserving surgical procedures (75%); joint lavage and arthroscopic debridement in knee ...

Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis

... significant and sustained improvements in the joint and skin manifestations of the disease, according ... the utility of this anti-TNF-alpha treatment." joint and Psoriatic Improvements Initial improvements ... an inflammation of a tendon, ligament or joint capsule insertion to the bone and dactylitis, ...

CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year

... for the inhibition of progression of structural joint damage in patients with active rheumatoid ... the inhibition of the progression of structural joint damage compared with placebo plus methotrexate at ... in inhibiting the progression of structural joint damage compared with placebo plus methotrexate at ...

IBA and Elekta Initiate Global Particle Therapy Program at ASTRO

... The collaboration will also include joint development of future integrated solutions that ... the proton therapy system, the IBA and Elekta joint development will make proton therapy system a ... of open systems design approach together with joint informal cooperation in the past, we have been ...

Facet Solutions' AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing

... screw stresses, and spinal stability of facet joint replacement versus dynamic stabilization devices. ... to provide controlled motion. By contrast, facet joint replacement allows for unconstrained motion ... in the spine joints; similar to hip and knee joint replacement devices. Recent studies have shown ...